Jb Chemicals Pharmaceuticals Stock Current Valuation
| JBCHEPHARM | 1,841 25.75 1.42% |
Valuation analysis of JB Chemicals Pharmac helps investors to measure JB Chemicals' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of now, JB Chemicals' Other Non Cash Items is increasing as compared to previous years. The JB Chemicals' current Total Cash From Operating Activities is estimated to increase to about 8.4 B, while Cash is projected to decrease to under 531 M. Fundamental drivers impacting JB Chemicals' valuation include:
Price Book 8.7854 | Enterprise Value 278.7 B | Enterprise Value Ebitda 27.5598 | Price Sales 7.7133 | Forward PE 21.692 |
Overvalued
Today
Please note that JB Chemicals' price fluctuation is very steady at this time. Calculation of the real value of JB Chemicals Pharmac is based on 3 months time horizon. Increasing JB Chemicals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since JB Chemicals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of JBCHEPHARM Stock. However, JB Chemicals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1840.75 | Real 1750.87 | Hype 1842.53 | Naive 1923.12 |
The intrinsic value of JB Chemicals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence JB Chemicals' stock price.
Estimating the potential upside or downside of JB Chemicals Pharmaceuticals helps investors to forecast how JBCHEPHARM stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of JB Chemicals more accurately as focusing exclusively on JB Chemicals' fundamentals will not take into account other important factors: JB Chemicals Pharmaceuticals Company Current Valuation Analysis
JB Chemicals' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current JB Chemicals Current Valuation | 278.7 B |
Most of JB Chemicals' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, JB Chemicals Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, JB Chemicals Pharmaceuticals has a Current Valuation of 278.7 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
JBCHEPHARM Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JB Chemicals' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of JB Chemicals could also be used in its relative valuation, which is a method of valuing JB Chemicals by comparing valuation metrics of similar companies.JB Chemicals is currently under evaluation in current valuation category among its peers.
JBCHEPHARM Fundamentals
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 278.7 B | ||||
| Shares Outstanding | 155.51 M | ||||
| Shares Owned By Insiders | 54.18 % | ||||
| Shares Owned By Institutions | 24.35 % | ||||
| Price To Book | 8.79 X | ||||
| Price To Sales | 7.71 X | ||||
| Revenue | 34.48 B | ||||
| Gross Profit | 19.81 B | ||||
| EBITDA | 9.33 B | ||||
| Net Income | 5.53 B | ||||
| Cash And Equivalents | 269.12 M | ||||
| Total Debt | 3.78 B | ||||
| Book Value Per Share | 206.82 X | ||||
| Cash Flow From Operations | 8.01 B | ||||
| Earnings Per Share | 39.02 X | ||||
| Target Price | 2173.77 | ||||
| Number Of Employees | 5.31 K | ||||
| Beta | -0.016 | ||||
| Market Capitalization | 286.26 B | ||||
| Total Asset | 39.94 B | ||||
| Retained Earnings | 25.13 B | ||||
| Working Capital | 9.85 B | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 39.94 B | ||||
| Last Dividend Paid | 6.75 |
About JB Chemicals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze JB Chemicals Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JB Chemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JB Chemicals Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in JBCHEPHARM Stock
JB Chemicals financial ratios help investors to determine whether JBCHEPHARM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in JBCHEPHARM with respect to the benefits of owning JB Chemicals security.